Quick Answer
Immix Biopharma, Inc. reported Shares Outstanding of 52.95 million shares for fiscal year 2025.
Immix Biopharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 52.95M | +92.3% |
| 2024 | 27.54M | +38.2% |
| 2023 | 19.92M | +43.4% |
| 2022 | 13.89M | +5.0% |
| 2021 | 13.23M | +292.0% |
| 2020 | 3.38M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 33.04M | +20.2% | +16.3% |
| June 30, 2025 | 28.41M | +3.6% | +2.0% |
| March 31, 2025 | 27.85M | +5.5% | +1.1% |
| December 31, 2024 | 27.54M | +38.2% | +0.2% |
| September 30, 2024 | 27.48M | +40.1% | +0.2% |
| June 30, 2024 | 27.43M | +68.7% | +3.9% |
| March 31, 2024 | 26.40M | +89.2% | +32.5% |
| December 31, 2023 | 19.92M | +43.4% | +1.6% |
- Immix Biopharma, Inc. showed an increase of +92.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Immix Biopharma, Inc.’s shares outstanding has grown by 1468.9% (from 3.38 million shares to 52.95 million shares).
- The most recent figure is from Immix Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: